21 December 2020
DLA Piper advises Arlington Capital Partners in majority investment in Everest Clinical Research Corporation
Advising firms
Deal team
18 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Jeffrey Houle Lead | DLA Piper | Partner | Aerospace, Defense and Government Services Transactional | Washington, DC |
| Russel Drew | DLA Piper | Partner | Not stated | Toronto |
| Thomas Pilkerton | DLA Piper | Partner | Not stated | Baltimore |
| Paolo Morante | DLA Piper | Partner | Not stated | New York |
| Christopher Mikson | DLA Piper | Partner | Not stated | Philadelphia |
| David Spratley | DLA Piper | Partner | Not stated | Vancouver |
| Veronica Monteiro | DLA Piper | Partner | Not stated | Edmonton |
| Qiang Li | DLA Piper | Partner | Not stated | Shanghai |
| Nia Brown | DLA Piper | Of counsel | Not stated | Washington, DC |
| Allen Xu | DLA Piper | Other | Not stated | Beijing |
| Ying Li | DLA Piper | Other | Not stated | Shanghai |
| Fangfang Song | DLA Piper | Other | Not stated | Beijing |
| Yiyuan Zhang | DLA Piper | Other | Not stated | Shanghai |
| Frank Chen | DLA Piper | Other | Not stated | Shanghai |
| Tina Xia | DLA Piper | Other | Not stated | Hong Kong |
| Mackenzie Clark | DLA Piper | Associate | Not stated | Toronto |
| Lauren Storwick | DLA Piper | Associate | Not stated | Calgary |
| Jordan Dugas | DLA Piper | Associate | Not stated | Edmonton |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Arlington Capital PartnersInvestor
- Counterparties
- Everest Clinical Research Corporation (Target)